Zdrowie i gospodarka · 19/05/2025

FDA to Host Public Meeting on Reauthorization of Prescription Drug User Fee Act

The FDA is hosting a public meeting to gather public input on proposed recommendations for reauthorizing the Prescription Drug User Fee Act for fiscal years 2028 through 2032, with comments to be published on the FDA website.